FIFTH AMENDMENT TO PLASMA PURCHASE AGREEMENTPlasma Purchase Agreement • January 2nd, 2019 • Adma Biologics, Inc. • Biological products, (no disgnostic substances)
This Fifth Amendment to the Plasma Purchase Agreement (this “Amendment #5”) by and between Grifols Worldwide Operations Limited, a corporation having a place of business at Grange Castle Business Park, Grange Castle, Clondalkin, Dublin 22, Ireland (“Grifols”), as the successor-in-interest to Biotest Pharmaceuticals Corporation, and ADMA Biologics, Inc., a Delaware corporation having a place of business at 465 Route 17 South, Ramsey, New Jersey 07446 (“ADMA”), is effective as of January 1, 2019 (the “Effective Date”).
